Click to enlargeCANINE SPECTRA 10 PLUS LYME

DURVET

Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine

Modified Live & Killed Virus

Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona

Bacterial Extract

FOR DOGS ONLY

KEEP PRODUCT REFRIGERATED

Indications: This product has been shown to be effective for the vaccination of healthy dogs 9 weeks of age or older against canine distemper virus (CDV), infectious canine hepatitis (CAV1), canine adenovirus type 2 (CAV2), canine coronavirus (CCV), canine parainfluenza (CPIV), and canine parvovirus (CPV), Leptospira canicola, Leptospira icterohaemorrhagiae, Leptospira grippotyphosa, Leptospira pomona and Borrelia burgdorferi (Bburg). The duration of immunity for Borrelia burgdorferi is at least 12 months. The duration of immunity for the other antigens has not been established. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Composition: Canine Spectra 10+Lyme vaccine is a combination of immunogenic, attenuated strains CDV, CAV2, CPIV, and CPV type 2b, propagated in cell line tissue cultures. The diluent contains killed CCV and Bburg antigens with Leptospira bacterial antigens. The CAV2 fraction has been shown to be effective against disease due to CAV1. The CPV2b strain has been demonstrated to be effective against CPV2c in puppies with CPV maternal antibody. Gentamicin and thimerosal added as preservatives.

Directions and dosage: Open the syringe by twisting or tapping the cap against a hard surface to break the heat weld. Aseptically rehydrate the vaccine cake with 1 ml of vaccine diluent supplied. SHAKE WELL. Withdraw entire contents into the syringe. Administer one 1 ml dose subcutaneously.

Subcutaneous administration: Lift the loose skin behind the neck or behind the front leg and insert needle (see illustration, arrows 1 and 2). Inject entire contents of syringe. Do not inject directly into blood vessel (see note below). IMPORTANT NOTE: Before injecting vaccine, pull back slightly on syringe plunger. If blood enters the syringe freely, choose another injection site. All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later. The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.


N3-A179

1 dose N3A179-1$15.47


Join Our Email List!
Email:  



Please contact us for discount pricing on large orders.
Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com